In order to observe the clinical efficacy of Ruyi Jinhuang Powder combined with ultrasonic iontophotosis in the treatment of multiple stele, 90 patients with multiple stele treated in the ophthalmology department of our hospital from January to June 2023 were randomly divided into the observation group and the control group, 45 cases in each group. The control group was treated with ofloxacin eye ointment, and the observation group was treated with Ruyi Jinhuang Powder combined with ultrasonic iontophoresis on the basis of the control group. The treatment cycle of both groups was 7 days. The clinical efficacy, visual analogue score (VAS) and the changes of tumor size were compared between the two groups to observe and compare the clinical efficacy. And pay attention to the side effects and adverse reactions of patients in the course of treatment. By observing and studying the therapeutic effect of all patients, we found that the total effective rate of the observation group was 88.89%, which was significantly higher than that of the control group (80.00%). After systemic treatment, the visual analogue scale (VAS) scores of both groups decreased significantly, but the decrease was greater in the observation group. In addition, the size of the mass after treatment was compared with that before treatment, and the intra-group comparison: both groups were smaller than that before treatment, the difference was statistically significant. Therefore, we have reached the following conclusion: the combination of Ruyi Jinhuang Powder and ultrasonic iontophoresis in the treatment of multiple stes can effectively help patients relieve pain and promote the elimination of eyelid sclerosis.